Does PANOBINOSTAT Cause Interstitial lung disease? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Interstitial lung disease have been filed in association with PANOBINOSTAT. This represents 0.6% of all adverse event reports for PANOBINOSTAT.
10
Reports of Interstitial lung disease with PANOBINOSTAT
0.6%
of all PANOBINOSTAT reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From PANOBINOSTAT?
Of the 10 reports, 2 (20.0%) resulted in death, 6 (60.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANOBINOSTAT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does PANOBINOSTAT Cause?
Diarrhoea (368)
Plasma cell myeloma (279)
Platelet count decreased (192)
Death (190)
Malignant neoplasm progression (166)
Fatigue (162)
Nausea (154)
Thrombocytopenia (141)
Off label use (112)
Vomiting (109)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which PANOBINOSTAT Alternatives Have Lower Interstitial lung disease Risk?
PANOBINOSTAT vs PANTOPRAZOLE
PANOBINOSTAT vs PANTOPRAZOLE ANHYDROUS
PANOBINOSTAT vs PANTOTHENIC ACID
PANOBINOSTAT vs PAPAVERINE
PANOBINOSTAT vs PARACETAMOL